Now livetag icon
2026 State of Ecommerce: Own the AI Shopper Journey.Download Reportbanner icon
CHIESI

August 2026

CHIESI Market Share Analysis for August 2026

Siamo un gruppo biofarmaceutico orientato alla ricerca che sviluppa e commercializza soluzioni terapeutiche innovative per la salute
Year Founded1935
Employees5001 - 10000
Annual Revenue> $1B
chiesi.com
CHIESI
CHIESI (including company regionals)
  • chiesi.com
    chiesi.com
See more website traffic and engagement information

CHIESI Revenue up to August 2026 is > 1B

revenue generated by CHIESI top domains

CHIESI top domains revenue over 3 years

Revenue for CHIESI top domains


Total visits to CHIESI's top domains

Understand CHIESI market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in CHIESI's top domains

Analyze CHIESI engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on CHIESI's top domains

See how CHIESI keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by CHIESI

These are the website technologies, by industry, used by CHIESI top domains

Social (6)

Facebook Connect

Facebook Connect

Advertising (4)

Google Adsense

Google Adsense

Widget (4)

reCAPTCHA

reCAPTCHA

Audio Video Media (3)

YouTube

YouTube

More Technologies

11

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from CHIESI

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsChiesi Group had revenue of $2.2B on Jun 30th '26.Chiesi reported revenues of €1.89 billion, representing growth of +3.6% at constant exchange rates (CER) compared with H1 2025.
NewsChiesi Group sold assets to Gossamer Bio in the amount of $5M on Aug 1st '26.Gossamer Bio, Inc. (NASDAQ:GOSS) also recently reacquired worldwide rights to seralutinib from Chiesi.
NewsChiesi Group is developing seralutinib for pulmonary hypertension on May 1st '24.In May 2024, Gossamer Bio and Chiesi Farmaceutici (the Chiesi Group) announced a worldwide partnership and licence agreement to develop and market seralutinib for pulmonary hypertension.

See all CHIESI signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.